Nasal antiviral blocks SARS-CoV-2 infection in mice
A key brain region for substance use disorders now has a searchable atlas of distinct cell populations
16 April 2022‘Magic mushrooms’ for therapy? Vets help sway conservatives
16 April 2022Nasal antiviral blocks SARS-CoV-2 infection in mice
SARS-CoV-2, the virus that causes COVID-19, has continuously mutated since it emerged in late 2019. This rapid evolution poses challenges for vaccines and treatments designed to target the virus. A booster shot is now needed to produce antibodies to fight off the Omicron variant of SARS-CoV-2. And several combinations of antibody treatments approved earlier in the pandemic don’t work well against Omicron.
